Targeted Whole-Exome Sequencing for Carrier Screening of Couples Having Previously Affected Pregnancies with Suspected Autosomal Recessive Diseases

Abstract

Introduction

There are many severe or life threatening autosomal recessive conditions leading to death in the prenatal, early postnatal, or early childhood period without a precise diagnosis being made. Often, genetic counselling and postmortem analysis are not available, and phenotypic descriptions are insufficient. Targeted whole exome sequencing of the couple is the best test when the proband is not available for sampling. It is estimated that couples with previous babies being affected by a particular phenotype are more likely to harbour a heterozygous variant for the given phenotype. Here, we report our experiences with targeted whole exome sequencing for the carrier screening of autosomal recessive lethal disorders in couples with one or more affected foetuses or children.

Methods

We selected 11 consanguineous and four nonconsanguineous consecutive couples at risk for severe autosomal recessive disorders seen at the genetic clinic of the Mahatma Gandhi Mission Medical College and Umang Maternity and IVF Centre. The couples were counseled for carrier screening with targeted next generation sequencing. The inclusion criteria included the loss of at least one child before the age of 2 years due to a severe/lethal condition and/or one or more miscarriages with pathological findings in the fetus. The couple's genetic testing results were reviewed to assess their risk of passing on inherited conditions to their children.

Results

A total of 15 couples were identified with a bad obstetric history in the last 2 years, from June 2022 to May 2024. Out of the 15 couples, 11 had a consanguineous union. Exome was negative in one couple, and only one parent harboured a pathogenic variant in another couple. Of the 15 couples investigated, 4 couples (cases 3, 11, 13, and 15) had lost one child. The remaining 11 couples had lost more than one pregnancy. A likely causative variant for the symptoms of the deceased children was identified in 5 out of the 15 couples investigated (33.33%). Out of the 12 couples, 5 couples were carriers of likely pathogenic variants, and the remaining 7 couples were carriers of variants of uncertain significance.

Conclusion

Our data showed that whole exome sequencing in couples based on phenotype in previous pregnancies or children was a high yield strategy for identifying lethal autosomal recessive disorders.

Keywords

whole-exome sequencing - carrier screening - bad obstetric history - autosomal recessive disorders

Name of the Department and Institution to which the Work should be Attributed

Institution: Department of Pediatrics, MGM Medical College, N-6, CIDCO, Aurangabad -431002; MGM Institute of Health Sciences (MGM IHS, Navi Mumbai) Maharashtra, India.

Author Contribution

S.M., G.M., and A.A. were involved in the review of literature, data collection, and wrote the first draft. S.M., G.M., D.K., A.D., L.R., and M.M. were involved in management of patients, designing of study, drafting the article, analysis and interpretation of data, and will act as guarantor. S.M., G.M., D.K., A.D., L.R., M.M., and A.A. were involved in the management of patients and data collection. The final manuscript was approved by all the authors.

Ethical Approval

The above study has been approved by ethical committee of MGM Medical College and University.

Publication History

Article published online:
25 July 2025

• References

• 1 Iglesias A, Anyane-Yeboa K, Wynn J. et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med 2014; 16 (12) 922-931
• 2 Zhang X, Chen Q, Li J. et al. The effectiveness of expanded carrier screening based on next-generation sequencing for severe monogenic genetic diseases. Hum Genomics 2024; 18 (01) 9
• 3 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 4 Accessed July 7, 2025 at: https://www.ncbi.nlm.nih.gov/clinvar/
• 5 Kennedy MP, Omran H, Leigh MW. et al. Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation 2007; 115 (22) 2814-2821
• 6 Milev MP, Grout ME, Saint-Dic D. et al. Mutations in TRAPPC12 manifest in progressive childhood encephalopathy and golgi dysfunction. Am J Hum Genet 2017; 101 (02) 291-299
• 7 Jagadeesh S, Suresh B, Murugan V. et al. Pyridoxine-dependent epilepsy owing to antiquitin deficiency--mutation in the ALDH7A1 gene. Paediatr Int Child Health 2013; 33 (02) 113-115
• 8 Yadav RM, Gupta M, Dalvi A. et al. Prenatal diagnosis for primary immunodeficiency disorders-an overview of the Indian scenario. Front Immunol 2020; 11: 612316
• 9 Mhatre S, Madkaikar M, Jijina F, Ghosh K. Unusual clinical presentations of familial hemophagocytic lymphohistiocytosis type-2. J Pediatr Hematol Oncol 2014; 36 (08) e524-e527
• 10 Sheth J, Patel A, Shah R, Bhavsar R, Trivedi S, Sheth F. Rare cause of hemophagocytic lymphohistiocytosis due to mutation in PRF1 and SH2D1A genes in two children - a case report with a review. BMC Pediatr 2019; 19 (01) 73
• 11 Stanley KE, Giordano J, Thorsten V. et al. Causal genetic variants in stillbirth. N Engl J Med 2020; 383 (12) 1107-1116
• 12 Gowda VK, Srinivasan VM, Jetha K. et al. Case series of ethylmalonic encephalopathy from Southern India. J Pediatr Genet 2021; 12 (03) 213-218
• 13 Scala M, Wortmann SB, Kaya N. et al. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat 2022; 43 (03) 403-419
• 14 Dijkstra AM, Evers-van Vliet K, Heiner-Fokkema MR. et al. A false-negative newborn screen for tyrosinemia type 1-need for re-evaluation of newborn screening with succinylacetone. Int J Neonatal Screen 2023; 9 (04) 66
• 15 Lewis AF, Carron JD, Vedanarayanan V. Congenital bilateral vocal fold paralysis and Charcot-Marie-Tooth disease. Ann Otol Rhinol Laryngol 2010; 119 (01) 47-49
• 16 Cottenie E, Kochanski A, Jordanova A. et al. Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2. Am J Hum Genet 2014; 95 (05) 590-601
• 17 Schottmann G, Jungbluth H, Schara U. et al. Recessive truncating IGHMBP2 mutations presenting as axonal sensorimotor neuropathy. Neurology 2015; 84 (05) 523-531
• 18 Bruel A-L, Bigoni S, Kennedy J. et al. Expanding the clinical spectrum of recessive truncating mutations of KLHL7 to a Bohring-Opitz-like phenotype. J Med Genet 2017; 54 (12) 830-835
• 19 Janssens S, Chokoshvili D, Vears DF, De Paepe A, Borry P. Pre- and post-testing counseling considerations for the provision of expanded carrier screening: exploration of European geneticists' views. BMC Med Ethics 2017; 18 (01) 46
• 20 Sharma SK, Kalam MA, Ghosh S, Roy S. Prevalence and determinants of consanguineous marriage and its types in India: evidence from the National Family Health Survey, 2015-2016. J Biosoc Sci 2021; 53 (04) 566-576
• 21 Reuter MS, Tawamie H, Buchert R. et al. Diagnostic yield and novel candidate genes by exome sequencing in 152 consanguineous families with neurodevelopmental disorders. JAMA Psychiatry 2017; 74 (03) 293-299
• 22 Huang Q, Wang Z, Teng Y. et al. Application of whole exome sequencing in carrier screening for high-risk families without probands. Front Genet 2024; 15: 1415811
• 23 Sallevelt SCEH, Stegmann APA, de Koning B. et al. Diagnostic exome-based preconception carrier testing in consanguineous couples: results from the first 100 couples in clinical practice. Genet Med 2021; 23 (06) 1125-1136
• 24 Zastrow DB, Kohler JN, Bonner D. et al; Undiagnosed Diseases Network. A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing. J Genet Couns 2019; 28 (02) 213-228 (Erratum in: J Genet Couns. 2019 Aug;28(4):915)
• 25 Komlosi K, Diederich S, Fend-Guella DL. et al. Targeted next-generation sequencing analysis in couples at increased risk for autosomal recessive disorders. Orphanet J Rare Dis 2018; 13 (01) 23